GeneDx Holdings Corp. Restructuring and Related Cost, Number of Positions Eliminated, Inception to Date Percent
GeneDx Holdings Corp. (WGS) had Restructuring and Related Cost, Number of Positions Eliminated, Inception to Date Percent of 32.50% as of 2023-06-30, per its 10-Q filed 2023-08-08.
Discontinued › Notes
us-gaap:RestructuringAndRelatedCostNumberOfPositionsEliminatedInceptionToDatePercent · last filed 2024-02-23
- 2023-06-30: Restructuring and Related Cost, Number of Positions Eliminated, Inception to Date Percent 32.50%.
- 2023-03-31: Restructuring and Related Cost, Number of Positions Eliminated, Inception to Date Percent 32.50%.
- 2022-12-31: Restructuring and Related Cost, Number of Positions Eliminated, Inception to Date Percent 32.50%.
| Period end | Restructuring and Related Cost, Number of Positions Eliminated, Inception to Date Percent |
|---|---|
| 2023-06-30 | 32.50% 10-Q · filed 2023-08-08 |
| 2023-03-31 | 32.50% 10-Q · filed 2023-05-09 |
| 2022-12-31 | 32.50% 10-K · filed 2024-02-23 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Privia Health Group, Inc. (PRVA) | United States | $2.477B | 115.52 |
| Pennant Group, Inc. (PNTG) | United States | $1.386B | 39.84 |
| U S PHYSICAL THERAPY INC /NV (USPH) | United States | $1.251B | 32.48 |
| Omada Health, Inc. (OMDA) | United States | $1.207B | 309.08 |
| InnovAge Holding Corp. (INNV) | United States | $1.206B | -635.60 |
| LifeStance Health Group, Inc. (LFST) | United States | $4.510B | 80.86 |
| Strata Critical Medical, Inc. (SRTA) | United States | $0.467B | 11.33 |
| DocGo Inc. (DCGO) | United States | $0.034B | -0.25 |
| VSEE HEALTH, INC. (VSEE) | United States | $0.003B | |
| Agape ATP Corp (ATPC) | $0.002B |